Product Overview
[Drug Name]
Generic Name: Nifedipine Sustained-Release Tablets
Trade Name: Xingai Da Nifedipine Sustained-Release Tablets (I) 20mg*30 Tablets*1 Bottle
Pinyin Full Code: XinGaiDa XiaoBenDiPingHuanShiPian(I) 20mg*30 Tablets*1 Bottle
[Main Ingredients]
The main ingredient of this product is nifedipine.
[Properties]
This product is a yellow tablet.
[Indications/Main Functions]
Chronic stable angina pectoris; vasospastic angina pectoris; primary angina pectoris.
[Specifications]
20mg*30 tablets*1 bottle
[Dosage and Administration]
Oral, once daily, initial dose 20mg (1 tablet). Depending on the condition and under the doctor's guidance, the dose may be increased to 40-60mg per dose. Do not refuse or break the tablets during this dose. [Adverse Reactions]
1. Liver: Jaundice and elevated glutamate oxaloacetate aminotransferase and glutamate pyruvate aminotransferase levels may occasionally occur. 2. Circulatory System: Chest pain, headache, flushing, dizziness, palpitations, decreased blood pressure, and lower limb edema may occasionally occur. 3. Allergies: Allergic symptoms such as hives and itching may occasionally occur. 4. Digestive System: Abdominal pain, nausea, loss of appetite, and constipation may occasionally occur. 5. Oral: Gingival hypertrophy may occur. 6. Metabolic Abnormalities: Hyperglycemia may occasionally occur.
[Contraindications]
This product is contraindicated in patients with allergies.
[Drug Interactions]
Drug interactions may occur if used concurrently with other medications. Consult your physician or pharmacist for details.
[Precautions]
1. When discontinuing calcium channel blockers, gradually reduce the dose. Do not discontinue medication without a physician's advice. 2. Use with caution in patients with hypotension. 3. Use with caution in patients with severe aortic valve stenosis or hepatic or renal insufficiency.
[Pediatric Use]
This product is contraindicated in children.
[Use in Elderly Patients]
See [Dosage and Administration] or follow your doctor's advice.
